Sciencepulse

FDA Reverses Course on Moderna's mRNA Flu Shot

Science·November 16, 2026

The Food and Drug Administration has agreed to review Moderna's mRNA flu vaccine, a sharp change of direction that caught many observers off guard. Regulators had been holding back from that review, so the decision opens a path for the shot to be assessed on its merits. The source material from Scientific American's Science Quickly roundup does not spell out the agency's reasoning, so the details of what comes next will matter.

Researchers also described a promising inhaled vaccine that could guard against several respiratory infections at once. Instead of a series of separate shots for different bugs, a single inhaled dose aimed at multiple pathogens would simplify protection against the viruses that spread each winter. The approach is still at an early stage, and it will need far more testing before it could reach patients.

A separate study ties air pollution to a higher risk of Alzheimer's disease. The findings add to a growing body of evidence that the air people breathe may affect the brain over time. Association does not prove cause, but the result strengthens the case for cleaner air as a public health issue.

Elsewhere, NASA reported a major milestone in the lead-up to Artemis II, the mission meant to return astronauts to the moon. The agency completed a wet dress rehearsal, a full run-through of fueling and countdown procedures. A newly disclosed problem with the rocket, however, has pushed the launch date back again.

In paleontology, scientists identified a new spinosaurid, a family of large, fish-eating dinosaurs. The find challenges long-held assumptions about where these animals lived, suggesting that researchers may need to rethink how spinosaurids moved between land and water.